Showing results (61-70 of 111) with videos related to
Sort By:
Pageof 12
JAMA Neurology|August 16, 2021
Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis: Data From 2 Different National StrategiesTim Spelman, Melinda Magyari, Fredrik Piehl, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 9, 2019
Comparative effectiveness of dimethyl fumarate as the initial and secondary treatment for MSMathias Granqvist, Joachim Burman, Martin Gunnarsson, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 22, 2012
MS risk genes are transcriptionally regulated in CSF leukocytes at relapseMargareta Jernås, Clas Malmeström, Markus Axelsson, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|April 30, 2015
Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trialRaymond Hupperts, Jan Lycke, Christine Short, et al.Journal of Neurology|April 7, 2026
Cerebrospinal fluid alpha-internexin concentrations measured in patients with Guillain-Barré syndrome: a possible prognostic biomarker for disability at 12 monthsNina Gleisner, Francisco Meda, Magnus Johnsson, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 17, 2012
Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosisKristin Augutis, Markus Axelsson, Erik Portelius, et al.European Journal of Neurology|April 16, 2025
Brain-Derived Tau as an Outcome Marker in Guillain-Barré Syndrome: A Retrospective Cohort StudyBrynhildur Hafsteinsdóttir, Fernando Gonzalez-Ortiz, Nina Gleisner, et al.Journal of Neurology|September 9, 2024
Neurofilament light chain as a diagnostic and prognostic biomarker in Guillain-Barré syndromeBrynhildur Hafsteinsdóttir, Helen Farman, Nina Lagerström, et al.Neurology|October 29, 2017
Monitoring disease activity in multiple sclerosis using serum neurofilament light proteinLenka Novakova, Henrik Zetterberg, Peter Sundström, et al.Journal of Neurochemistry|April 21, 2018
Sulfatide isoform pattern in cerebrospinal fluid discriminates progressive MS from relapsing-remitting MSLenka Novakova, Avadhesh Kumar Singh, Markus Axelsson, et al.Pageof 12